Trusted by:
PRECLINICAL
DEVELOPMENT
CLINICAL DEVELOPMENT
Phase 1 | Phase 2 | Phase 3
LAUNCH /
POST LAUNCH
BRAND MATURITY
Phase 4
Trusted by Top-20 Pharma and 100+ small and medium Biotechs
Rate working with us 9 or 10/10
For leading high-science Pharma and Biotechs
Including two from Science and NSF
6 medical animaiton styles, 20 subtypes to meet audience and budget needs
Proprietary production platform speeds up process without compromising quality at an average price tag
Digtial content/asset channel planning upfront
Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.
The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.
The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.
Featured:
A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.
This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy.
Scientific accuracy
Cost per minute
High
Content Focus:
Dermatology, wound healing
Animation type:
3D + High-End 3D
Time:
7 weeks
Client time commitment:
5 zooms + 4 e-mail feedback sessions
Client contact:
Ofer Gonen
Chief Executive Officer
https://www.linkedin.com/in/ofer-gonen/
See in full resolution: https://visual-science.com/mediwound
Content Focus:
Oncology, EGFR-RAS signaling
Animation type:
3D + High-end 3D
Time:
12 weeks (including longer MLR process)
Content Focus:
Oncology, MAPK signaling cascade
Animation type:
Deck3D + High-end 3D
Time:
9 weeks
Content Focus:
Inflammation, oncology, IL-18 signaling, IL-18 modifications and therapy
Animation type:
Deck3D + High-end 3D
Time:
8 weeks
Content Focus:
CNS, oncology, small molecule drugs as part of gene therapy
Animation type:
3D + High-end 3D
Time:
8 weeks
Content Focus:
Oncology, viral immunotherapy
Animation type:
Main 3D + High-end 3D
Time:
15 weeks (client requested and extended the review timeframe for each of the 4 review steps)
Client contact:
Caitlyn Doherty
Senior Communications and IR Associate
https://www.linkedin.com/in/caitlyn-doherty/
Content Focus:
Small molecule drug design
Animation type:
3D + 2D, with High-end 3D Elements
Time:
10 weeks
Client time commitment:
5 zoom calls + e-mails
Client contact:
Ravi Moorthy, VP, Head of Communications
https://www.linkedin.com/in/ravi-moorthy-31857a1/
See in full resolution: https://visual-science.com/scorpion
Content Focus:
CNS pathologies
Animation type:
3D
Time:
8 weeks
Client time commitment:
2 zoom calls + 5 e-mails
Client contact:
Elma Hawkins,
President and Founder
https://www.linkedin.com/in/elma-hawkins-74a37a4/
See in full resolution: https://visual-science.com/redpin
Content Focus:
Small molecule prodrug delivery
Animation type:
Main 3D + High-end 3D
Time:
4 zoom calls + 4 e-mail feedback sessions
Client contact:
Janice Zang, PhD
Co-Founder & CEO
https://www.linkedin.com/in/xiaoyuzang
Content Focus:
Oncology, biologics
Animation type:
Deck3D + High-end 3D
Time:
6 weeks
Scientific Platform & Lexicon Development
Digital Content Library & Channel Planning
MOD/MOA Assets (Optimized)
Disease & Product Decks
Engagement & Training Apps
HCP AI and AI assistants
MOD/MOA Assets (Optimized)
PosterAR platform
Interactive Booth Displays
AR & VR Experiences
AI Assistants
MOD/MOA Assets (Optimized)
Websites & Web Apps
Corporate & Investor Decks
AI Assistants
CONTACT:
Michael J. Russo
Growth Consultant I Strategic Partnerships
mr@visual-science.com
770.658.9326